[1] Chinese Society of Infectious Diseases,Chinese Medical Association; Chinese GRADE Center. 2019 Chinese practice guideline for the prevention and treatment of hepatitis B virus mother-to-child transmission[J]. Chin J Infect Dis,2019,37(7):388-396.(in Chinese)中华医学会感染病学分会,GRADE中国中心.中国乙型肝炎病毒母婴传播防治指南(2019年版)[J].中华传染病杂志,2019,37(7):388-396.
|
[2] ZHOU YH,LI T,ZHUANG H. Comments on“2019 Chinese practice guideline for the prevention and treatment of hepatitis B virus mother-to-child transmission”[J]. J Clin Hepatol,2020,36(1):59-61.(in Chinese)周乙华,李彤,庄辉.对“《中国乙型肝炎病毒母婴传播防治指南(2019年版)》”的商榷[J].临床肝胆病杂志,2020,36(1):59-61.
|
[3] LIU JF,CHEN TY,CHEN YL,et al. Response to the article of“comments on 2019 Chinese practice for the prevention and treatment of hepatitis B virus mother-to-child transmission”[J]. J Clin Hepatol,2020,36(1):62-64.(in Chinese)刘锦锋,陈天艳,陈耀龙,等.对《对〈中国乙型肝炎病毒母婴传播防治指南(2019年版)〉的商榷》一文的回复[J].临床肝胆病杂志,2020,36(1):62-64.
|
[4] TERRAULT NA,LOK ASF,McMAHON BJ,et al. Update on prevention,diagnosis,and treatment of chronic hepatitis B:AASLD 2018 hepatitis B guidance[J]. Hepatology,2018,67(4):1560-1599.
|
[5] European Association for the Study of the Liver. EASL 2017clinical practice guidelines on the management of hepatitis B virus infection[J]. J Hepatol,2017,67(2):370-398.
|
[6] Chinese Society of Infectious Diseases,Chinese Medical Association; Chinese Society of Hepatology,Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B(version 2019)[J]. J Clin Hepatol,2019,35(12):2648-2669.(in Chinese)中华医学会感染病学分会,中华医学会肝病学分会.慢性乙型肝炎防治指南(2019年版)[J].临床肝胆病杂志,2019,35(12):2648-2669.
|